Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.
Christopher Cole
Advertisement
Associate Editorial Director
Articles by Christopher Cole
Grifols received FDA clearance to begin a Phase II trial of GRF312, an immunoglobulin eye drop for dry eye disease, aiming to improve current treatments.
ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized supplement capsules based on individual health data.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of January 26, 2026
2
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
3
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
4
Women in STEM: Inspiration from Innovators in Pharma
5